CHICAGO -- Treatment with intravenous ferric derisomaltose showed a non-significant trend toward lower risks of hospital admission and cardiovascular death among patients with heart failure, reduced ...

Intravenous iron reduced iron deficiency more effectively than oral iron, which is often distasteful, among pregnant women in Nigeria. However, no significant difference was found in the prevalence of ...

The success of IV iron supplementation in improving responses to ESAs in the anemia of end-stage renal disease has yet to be realized by the oncology community. Oncologists spend three times more on ...

CHICAGO — In the IRONMAN trial, long-term IV iron supplementation in patients with HF and iron deficiency was safe and reduced risk for recurrent HF hospitalizations and CV death compared with usual ...

Two products commonly administered intravenously to replenish iron levels in the body have a much higher chance of provoking a severe allergic attack, according to Rutgers researchers who conducted a ...

Ferumoxytol, a novel intravenous form of iron that permits rapid administration of large doses, has been shown to be effective for treating iron deficiency in chronic kidney disease (CKD) patients on ...

Dublin, July 09, 2025 (GLOBE NEWSWIRE) -- The "Intravenous Iron Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type" ...

Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron supplementation was found to be safe but resulted in mixed findings, according to a ...